VOTING AGREEMENTVoting Agreement • June 24th, 2005 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware
THIS VOTING AGREEMENT (this “Agreement”) is made and entered into as of June 20, 2005, by and among Clinical Data, Inc., a Delaware corporation (“Clinical Data”), Genaissance Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Randal J. Kirk (“Kirk”), RJK, L.L.C., a Virginia limited liability company that is controlled by Kirk (“RJK”), New River Management II, LP, a Virginia limited partnership that is controlled by Kirk (“New River”), Kirkfield, L.L.C., a Virginia limited liability company that is controlled by Kirk (“Kirkfield”), Third Security Staff 2001 LLC, a Virginia limited liability company (“Staff LLC”), and Zhong Mei, L.L.C., a Virginia limited liability company (“Zhong Mei”, and collectively with Kirk, RJK, New River, and Staff LLC, the “Stockholders”, and each individually, a “Stockholder”).
VOTING AGREEMENTVoting Agreement • June 24th, 2005 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware
THIS VOTING AGREEMENT (this “Agreement”) is made and entered into as of June 20, 2005, by and among Genaissance Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Clinical Data, Inc., a Delaware corporation (“Clinical Data”), and RAM Trading, Ltd., a Cayman Islands exempted company (the “Stockholder”).
VOTING AGREEMENTVoting Agreement • June 24th, 2005 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware
THIS VOTING AGREEMENT (this “Agreement”) is made and entered into as of June 20, 2005, by and among Clinical Data, Inc., a Delaware corporation (“Clinical Data”), Genaissance Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Israel M. Stein, M.D. (the “Stockholder”).
AGREEMENT AND PLAN OF MERGER by and among CLINICAL DATA, INC., SAFARI ACQUISITION CORPORATION and GENAISSANCE PHARMACEUTICALS, INC. Dated as of June 20, 2005Merger Agreement • June 24th, 2005 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of June 20, 2005, is by and among Clinical Data, Inc., a Delaware corporation (the “Parent”), Safari Acquisition Corporation, a Delaware corporation and a wholly-owned subsidiary of the Parent (the “Transitory Subsidiary”), and Genaissance Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
